Various locations | San Francisco, CA
Join KPMG at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco, CA, January 13-16, 2020. We will be hosting a series of premier events where you will learn from our top strategy, legal, and financial partners and engage with luminaries across the life sciences and healthcare industries about the future of innovation and dealmaking worldwide.
You won't want to miss this opportunity to get forward-thinking perspectives and insights on key life sciences and healthcare topics. Please register for these sessions as seating is limited!
We look forward to seeing you at the J.P. Morgan Healthcare Conference!
See session tabs above for descriptions, agendas, and registration details.
Healthcare industry leader panel
When: Monday, January 13, 4:00 pm PT
Where: KPMG offices, 55 2nd Street, San Francisco, CA
The healthcare industry is increasingly under pressure to demonstrate the value of care being delivered, while also aiming to improve patient experience and empowering them to make informed decisions. The emphasis on controlling costs and maintaining high quality necessitates developing innovative approaches and technologies that can meet patient needs and demands across the care continuum. This distinguished panel of business leaders will discuss how their organizations are navigating the evolving healthcare market through unique partnerships, innovations, and investments that move the healthcare system to a value-driven industry, all in the face of ongoing regulatory and legislative reforms.
Health Care Investment Outlook 2020
- Monday, January 13, 1:00 pm PT
- Tuesday, January 14, 8:00 am PT or 2:00 pm PT
All Briefing Sessions full!
If you would like to be put on the waiting list, please click here. We will contact you if space becomes available.
Where: Sir Francis Drake Hotel, 450 Powell Street, San Francisco, CA
KPMG will unveil the results from our annual healthcare and life sciences investment landscape survey, and provide insights on factors driving market changes, policy and regulatory disruptors, and investor considerations for 2020. The KPMG authors of the report will be discussing its findings and implications with senior leaders from Leavitt Partners, including Governor Mike Leavitt, former Secretary of U.S. Department of Human Health and Services (HHS).
We hope you can join us for this exciting and timely discussion on insights from our survey about what to expect from the healthcare and life sciences investment landscape for 2020.
Learn with Us: Goodwin + KPMG @ JPMorgan Symposium at the St. Regis Hotel
When: Wednesday, January 15, 8:30 am - 6:15 pm PT
Where: St. Regis, 125 3rd Street, San Francisco, CA
Registration closed! If you would like to be put on the waiting list, please click here. We will contact you if space becomes available.
Learn with us at this special symposium co-hosted by Goodwin + KPMG on Wednesday, January 15, 8:30 am - 6:15 pm.
The symposium will provide the latest insights and perspectives from healthcare and life sciences industry professionals and will address key topics including:
Goodwin + KPMG @ JPMorgan Symposium
8:30 am – 8:45 am Welcome Remarks
Burst 1 | New Frontiers in Digital Diagnostics & Medtech
8:50 am – 9:05 am Current State of the Healthcare Sector & Regulations
9:10 am – 9:55 am New Frontiers in MedTech Space on the Global Stage: What are the Challenges in IP, Regulatory and Commercial
10:00 am – 10:45 am Panel: Issues Facing Therapeutic Companies Using ML and AI in Drug Discovery Methods
10:55 am – 11:40 am Keynote Speaker - Stéphane Bancel, CEO, Moderna
11:40 am – 12:10 pm Lunch Break
Burst 2 | Europe Unleashed
12:10 pm – 12:40 pm The Evolving Landscape for Growth-Stage Venture Funding in Europe
12:45 pm – 1:15 pm Maximizing Returns through Structured M&As
Burst 3 | Knowing the Best IPO Strategy
1:20 pm – 1:40 pm 2020 Vision for the IPO Market
1:40 pm – 2:10 pm Traditional US IPO Route: “The Two Minute Drill” to Complete a Successful IPO in the First Six Months of the Year
2:15 pm – 2:45 pm Hong Kong IPO: Seizing Opportunities in a New Emerging Market for Biotech IPOs
2:50 pm – 3:20 pm Alternatives to U.S. IPO: Reverse Mergers and Direct Listings
3:20 pm – 3:30 pm Coffee & Networking
Burst 4 | Trends in Biopharma
3:30 pm – 4:10 pm Evaluating and Partnering New Technologies and Emerging Business Models
Burst 5 | Mergers and Acquisitions
4:15 pm – 5:15 pm The Brave New World of Antitrust in Life Sciences M&A
5:15 pm – 6:15 pm Cocktails & Networking
Event co-hosted by:
Carole Streicher, National Lead Partner Healthcare & Life Sciences Deal Advisory